Literature DB >> 15181089

Glucocorticoids down-regulate glucose uptake capacity and insulin-signaling proteins in omental but not subcutaneous human adipocytes.

M Lundgren1, J Burén, T Ruge, T Myrnäs, J W Eriksson.   

Abstract

Visceral adiposity is associated with insulin resistance and type 2 diabetes. This study explores the metabolic differences between s.c. and visceral fat depots with respect to effects in vitro of glucocorticoids and insulin on glucose uptake. Adipocytes from human s.c. and omental fat depots were obtained during abdominal surgery in 18 nondiabetic subjects. Cells were isolated, and metabolic studies were performed directly after the biopsies and after a culture period of 24 h with or without dexamethasone. After washing, basal and insulin-stimulated [14C]glucose uptake as well as cellular content of insulin signaling proteins and glucose transporter 4 (GLUT4) was assessed. Omental adipocytes had an approximately 2-fold higher rate of insulin-stimulated glucose uptake compared with s.c. adipocytes (P < 0.01). Dexamethasone treatment markedly inhibited (by approximately 50%; P < 0.05) both basal and insulin-stimulated glucose uptake in omental adipocytes but had no consistent effect in s.c. adipocytes. The cellular content of insulin receptor substrate 1 and phosphatidylinositol 3-kinase did not differ significantly between the depots, but the expression of protein kinase B (PKB) tended to be increased in omental compared with s.c. adipocytes (P = 0.09). Dexamethasone treatment decreased the expression of insulin receptor substrate 1 (by approximately 40%; P < 0.05) and PKB (by approximately 20%; P < 0.05) in omental but not in s.c. adipocytes. In contrast, dexamethasone pretreatment had no effect on insulin-stimulated Ser473 phosphorylation of PKB. GLUT4 expression was approximately 4-fold higher in omental than s.c. adipocytes (P < 0.05). Dexamethasone treatment did not alter the expression of GLUT4. In conclusion, human omental adipocytes display approximately 2-fold higher glucose uptake rate compared with s.c. adipocytes, and this could be explained by a higher GLUT4 expression. A marked suppression is exerted by glucocorticoids on glucose uptake and on the expression of insulin signaling proteins in omental but not in s.c. adipocytes. These findings may be of relevance for the interaction between endogenous glucocorticoids and visceral fat in the development of insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15181089     DOI: 10.1210/jc.2003-031157

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  48 in total

1.  Glucocorticoid receptor ChIP-sequencing of subcutaneous fat reveals modulation of inflammatory pathways.

Authors:  Puneet Singh; Clifton O Brock; Paul A Volden; Kyle Hernandez; Maxwell Skor; Masha Kocherginsky; Julie E Park; Matthew J Brady; Suzanne D Conzen
Journal:  Obesity (Silver Spring)       Date:  2015-09-26       Impact factor: 5.002

2.  Surface protein expression between human adipose tissue-derived stromal cells and mature adipocytes.

Authors:  Franck Festy; Laurence Hoareau; Sandrine Bes-Houtmann; Anne-Marie Péquin; Marie-Paule Gonthier; Ashik Munstun; Jean Jacques Hoarau; Maya Césari; Régis Roche
Journal:  Histochem Cell Biol       Date:  2005-09-29       Impact factor: 4.304

3.  Insulin sensitization of human preadipocytes through glucocorticoid hormone induction of forkhead transcription factors.

Authors:  Julianna J Tomlinson; Adèle Boudreau; Dongmei Wu; Houssein Abdou Salem; Amanda Carrigan; AnneMarie Gagnon; Alan J Mears; Alexander Sorisky; Ella Atlas; Robert J G Haché
Journal:  Mol Endocrinol       Date:  2009-11-03

4.  Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trial.

Authors:  D H van Raalte; M Brands; N J van der Zijl; M H Muskiet; P J W Pouwels; M T Ackermans; H P Sauerwein; M J Serlie; M Diamant
Journal:  Diabetologia       Date:  2011-05-12       Impact factor: 10.122

5.  Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia'.

Authors:  M Lundgren; M Svensson; S Lindmark; F Renström; T Ruge; J W Eriksson
Journal:  Diabetologia       Date:  2007-01-10       Impact factor: 10.122

6.  Unravelling hair follicle-adipocyte communication.

Authors:  Barbara Schmidt; Valerie Horsley
Journal:  Exp Dermatol       Date:  2012-11       Impact factor: 3.960

7.  Naturally occurring compensated insulin resistance selectively alters glucose transporters in visceral and subcutaneous adipose tissues without change in AS160 activation.

Authors:  A P Waller; K Kohler; T A Burns; M C Mudge; J K Belknap; V A Lacombe
Journal:  Biochim Biophys Acta       Date:  2011-02-23

8.  Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics.

Authors:  Jon T Giles; Matthew Allison; Roger S Blumenthal; Wendy Post; Allan C Gelber; Michelle Petri; Russell Tracy; Moyses Szklo; Joan M Bathon
Journal:  Arthritis Rheum       Date:  2010-11

Review 9.  Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism.

Authors:  Eliza B Geer; Julie Islam; Christoph Buettner
Journal:  Endocrinol Metab Clin North Am       Date:  2014-03       Impact factor: 4.741

Review 10.  Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer?

Authors:  X Yang; U Smith
Journal:  Diabetologia       Date:  2007-03-29       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.